X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (37) 37
humans (35) 35
female (32) 32
middle aged (25) 25
aged (21) 21
adult (20) 20
breast cancer (19) 19
prognosis (18) 18
chemotherapy (16) 16
male (14) 14
breast neoplasms - pathology (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
index medicus (11) 11
carcinoma (10) 10
cancer (9) 9
medicine & public health (8) 8
retrospective studies (8) 8
survival (8) 8
survival analysis (8) 8
cisplatin (7) 7
breast neoplasms - drug therapy (6) 6
hematology, oncology and palliative medicine (6) 6
immunohistochemistry (6) 6
receptors, estrogen - analysis (6) 6
treatment outcome (6) 6
cooperative-oncology-group (5) 5
disease-free survival (5) 5
italy (5) 5
therapy (5) 5
time factors (5) 5
aged, 80 and over (4) 4
care and treatment (4) 4
cisplatin - administration & dosage (4) 4
ki-67 antigen - metabolism (4) 4
ki67 (4) 4
metastatic melanoma (4) 4
multivariate analysis (4) 4
neoadjuvant (4) 4
neoadjuvant therapy (4) 4
paclitaxel (4) 4
pathological complete response (4) 4
randomized controlled trials as topic (4) 4
5-ht3 antagonists (3) 3
analysis (3) 3
antibodies, monoclonal (3) 3
antiemetics (3) 3
antineoplastic agents - therapeutic use (3) 3
benefit (3) 3
breast neoplasms - immunology (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - mortality (3) 3
breast neoplasms - surgery (3) 3
combination (3) 3
communication (3) 3
dacarbazine - administration & dosage (3) 3
diagnosis (3) 3
estrogen-receptors (3) 3
follow-up (3) 3
follow-up studies (3) 3
k dm oncology (3) 3
ki-67 (3) 3
medicine, research & experimental (3) 3
melanoma - drug therapy (3) 3
metastasis (3) 3
metastatic carcinoma (3) 3
neoplasm staging (3) 3
neoplasms, unknown primary - drug therapy (3) 3
open-label (3) 3
phase-ii (3) 3
preoperative chemotherapy (3) 3
prognostic-significance (3) 3
prospective studies (3) 3
quality of life (3) 3
research (3) 3
sections (3) 3
skin neoplasms - drug therapy (3) 3
surgical adjuvant breast (3) 3
systemic treatment (3) 3
taxoids - administration & dosage (3) 3
trastuzumab (3) 3
trial (3) 3
tyrosine kinase inhibitors (3) 3
vomiting - chemically induced (3) 3
vomiting - prevention & control (3) 3
young adult (3) 3
1506 (2) 2
1717 (2) 2
1722 (2) 2
adolescent (2) 2
antiemetics - administration & dosage (2) 2
antiemetics - therapeutic use (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bevacizumab (2) 2
bio-chemotherapy (2) 2
biochemistry (2) 2
bisphosphonates (2) 2
bone marrow (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurological Sciences, ISSN 1590-1874, 1/2015, Volume 36, Issue 1, pp. 117 - 123
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2016, Volume 27, Issue suppl_4, pp. iv62 - iv62
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2002, Volume 20, Issue 6, pp. 1600 - 1607
Purpose: Phase II and III studies have shown that the addition of interleukin-2 (IL-2) and interferon alfa-2b (IFNalpha-2b) in multiagent chemotherapy (CT) for... 
METASTATIC MALIGNANT-MELANOMA | THERAPY | ONCOLOGY | CHEMOIMMUNOTHERAPY | TAMOXIFEN | CUTANEOUS MELANOMA | ALPHA | REGIMEN | COMBINATION | CHEMOTHERAPY | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
Journal Article